White Pine Investment CO Acquires 4,625 Shares of Evolent Health Inc (EVH)
White Pine Investment CO grew its position in Evolent Health Inc (NYSE:EVH) by 2.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 162,300 shares of the technology company’s stock after purchasing an additional 4,625 shares during the period. White Pine Investment CO owned about 0.20% of Evolent Health worth $2,042,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the company. Thrivent Financial for Lutherans raised its holdings in shares of Evolent Health by 0.4% in the fourth quarter. Thrivent Financial for Lutherans now owns 198,933 shares of the technology company’s stock valued at $3,969,000 after purchasing an additional 751 shares during the last quarter. Parkside Financial Bank & Trust increased its holdings in Evolent Health by 57.7% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,628 shares of the technology company’s stock worth $72,000 after buying an additional 1,327 shares during the last quarter. State Board of Administration of Florida Retirement System boosted its position in Evolent Health by 7.6% during the fourth quarter. State Board of Administration of Florida Retirement System now owns 24,749 shares of the technology company’s stock worth $494,000 after purchasing an additional 1,758 shares during the period. Legal & General Group Plc boosted its position in Evolent Health by 7.1% during the fourth quarter. Legal & General Group Plc now owns 27,695 shares of the technology company’s stock worth $553,000 after purchasing an additional 1,838 shares during the period. Finally, Pier 88 Investment Partners LLC boosted its position in Evolent Health by 10.2% during the fourth quarter. Pier 88 Investment Partners LLC now owns 24,930 shares of the technology company’s stock worth $497,000 after purchasing an additional 2,315 shares during the period.
A number of equities analysts have weighed in on the stock. Cantor Fitzgerald reiterated a “buy” rating and set a $37.00 target price on shares of Evolent Health in a research report on Monday, December 31st. Zacks Investment Research lowered shares of Evolent Health from a “buy” rating to a “hold” rating in a research report on Friday, January 4th. ValuEngine upgraded shares of Evolent Health from a “hold” rating to a “buy” rating in a research report on Monday, February 4th. Finally, Wells Fargo & Co cut their price objective on shares of Evolent Health from $34.00 to $21.50 and set an “outperform” rating for the company in a research report on Wednesday, February 27th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $26.54.
Evolent Health (NYSE:EVH) last posted its quarterly earnings results on Tuesday, February 26th. The technology company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.02). The business had revenue of $193.10 million for the quarter, compared to analysts’ expectations of $188.66 million. Evolent Health had a negative return on equity of 2.39% and a negative net margin of 8.40%. The company’s revenue was up 69.8% compared to the same quarter last year. During the same period last year, the business posted ($0.04) earnings per share. On average, research analysts predict that Evolent Health Inc will post -0.81 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This article was reported by Marea Informative and is the property of of Marea Informative. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.mareainformativa.com/news/2019/04/23/white-pine-investment-co-acquires-4625-shares-of-evolent-health-inc-evh.html.
Evolent Health Profile
Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.
Featured Article: Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.